Clinical Trial: TILs Therapy for Multiple Primary Early-Stage NSCLC

U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT07498439) titled 'TILs Therapy for Multiple Primary Early-Stage NSCLC' on March 16.

Brief Summary: This is a single-arm study aimed at evaluating the safety of TILs therapy for multiple primary early-stage NSCLC

Study Start Date: March 31

Study Type: INTERVENTIONAL

Condition: Primary Early-stage Non-small Cell Lung Cancer

Intervention: DRUG: TILs injection

Experimental: Surgically collect fresh tumor tissue or malignant pleural effusion to isolate immune cells, and prepare TILs Infusion. Trial product: TILs Injection. Administration route: Intravenous Infusion

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Tianjin Medical University Genera...